Skip to content
Unrated Drug recall · FDA · Published December 7, 2022

Lupin Quinapril Tablets 20mg Recall: N-Nitroso Impurity Risk

Lupin Pharmaceuticals recalls 20mg Quinapril tablets due to N-Nitroso impurity exceeding safety limits. Affected lots may pose health risks. Contact for return instructions.

🇺🇸 FDA recall #D-0089-2023DrugLupin ›
Take action

Contact the company

Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer

Lupin Pharmaceuticals is recalling 20mg Quinapril tablets (90-pack) because they contain an impurity that could exceed safe levels. This recall affects prescription-only medication that was manufactured in specific lots and may pose health risks if taken. Read more at govinfonow.com/recall/34194-lupin-quinapril-tablets-20mg-recall-n-nitroso-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/34194-lupin-quinapril-tablets-20mg-recall-n-nitroso-impurity-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0089-2023

Cite this page

“Lupin Quinapril Tablets 20mg Recall: N-Nitroso Impurity Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34194-lupin-quinapril-tablets-20mg-recall-n-nitroso-impurity-risk. Based on FDA recall #D-0089-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0089-2023%22&limit=1).

Lupin Pharmaceuticals Inc. recalled Quinapril Tablets USP, 20 mg (90 pack) on Dec. 7, 2022, due to CGMP deviations involving an impurity above acceptable limits, the FDA said. The voluntary Class II recall affects 23,736 units distributed nationwide.

How to tell if you have it

  • Brand: Lupin
  • Product: Quinapril Tablets USP, 20 mg (90 pack), Rx Only
  • NDC#: 68180-558-09
  • Lot #: G102929
  • Expiration: 04/2023

The hazard

The recall addresses CGMP deviations related to the detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit, according to the FDA.

Context

GovInfoNow's records show Lupin Pharmaceuticals Inc. has had 90 other recalls since Jan. 31, 2013. Recent brand actions include a Lupin Clobetasol Cream recall on Aug. 3, 2026, for failed content uniformity and a Lupin Glucagon Emergency Kit recall on June 23, 2026, for CGMP deviation risk. Other recent recalls of similar products include Asclemed Duloxetine Capsules Recall (May 14, 2026), Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026), and Cipla Cinacalcet Tablets Recall (Nov. 14, 2025).

How to tell if you have this one

Check for the product name 'Quinapril Tablets USP 20mg (90 pack)', prescription-only status, and lot number G102929 (expiring April 2023). The NDC code 68180-558-09 is also a key identifier.

  • Brand
    Lupin
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Product was distributed by major distribution chains nationwide.
  • NDC
    68180-556-09, 68180-557-09, 68180-557-03, 68180-558-09, 68180-558-03, 68180-554-09, 68180-554-03, 68180-559-03, 68180-559-09
Recall numberProduct, codes & lotsQuantity
D-0088-2023Quinapril Tablets USP, 40 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-554-09; Lot #: G100533, G100534, Exp. 12/2022; G203071, Exp. 03/202430,612 bottles
D-0089-2023Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09; Lot #: G102929, Exp 04/202323,736
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product name, lot number, and expiration date to confirm if your tablets are affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed by major distribution chains nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Dec 7, 202212. FDA classified it Class II: Dec 23, 202223. Published in FDA’s Enforcement Report: Dec 28, 202234. FDA terminated the recall: Aug 1, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Lupin recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0089-2023 (December 7, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0089-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA